aloe emodin has been researched along with Neuroectodermal Tumors in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bet, A; Carli, M; Dalla Vecchia, F; Diaspro, A; Gatto, B; Palù, G; Palumbo, M; Pecere, T; Salata, C; Sarinella, F | 1 |
Basso, G; Carli, M; Cavaggioni, A; Diaspro, A; Gazzola, MV; Mucignat, C; Palù, G; Parolin, C; Pecere, T; Salvato, B; Vecchia, FD | 1 |
2 other study(ies) available for aloe emodin and Neuroectodermal Tumors
Article | Year |
---|---|
Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin.
Topics: Anthraquinones; Apoptosis; Benzothiazoles; Blotting, Western; Caspases; Cell Cycle; Child, Preschool; Cytochromes c; DNA Primers; DNA Topoisomerases, Type II; DNA, Neoplasm; Emodin; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Male; Microscopy, Immunoelectron; Mitochondria; Mutation; Neuroectodermal Tumors; Poly(ADP-ribose) Polymerases; Protein Transport; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2003 |
Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Apoptosis; Cell Cycle; Dose-Response Relationship, Drug; Emodin; Enzyme Inhibitors; Female; Flow Cytometry; HeLa Cells; Hematopoietic Stem Cells; Humans; Mice; Mice, SCID; Microscopy, Electron; Models, Chemical; Neuroectodermal Tumors; Time Factors; Tumor Cells, Cultured | 2000 |